The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for ...

Novo Nordisk's newly approved weight-loss pill version of Wegovy will be a test case for the fast-growing cash-paying ...

The FDA has approved the first-ever Wegovy pill for weight loss, with the oral GLP-1 offering a 16.6% average weight ...

In the studies the company submitted to the FDA, people who took the daily Wegovy pill lost about the same amount of ...

The FDA has approved a pill form of the popular GLP-1 weight-loss medication Wegovy. Novo Nordisk says it is as effective as ...

On Monday evening, the Food and Drug Administration approved Novo Nordisk’s high-dose oral formulation of semaglutide for ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster ...

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

The Wegovy pill is FDA-approved to reduce excess body weight and maintain weight reduction long-term in adults who have ...

Novo Nordisk (NVO) stock gains as the FDA approves the company's Wegovy pill, as Eli Lilly (LLY) awaits FDA review for its ...